Ventripoint Diagnostics Ltd. (TSXV:VPT)
Canada · Delayed Price · Currency is CAD 0.0900
0.00 (0.00%)
Oct 22, 2026, 10:55 AM EDT
Ventripoint Diagnostics Revenue
Ventripoint Diagnostics had revenue of 19.58K CAD in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 247.77K, up 23.68% year-over-year. In the year 2025, Ventripoint Diagnostics had annual revenue of 179.93K with 89.06% growth. That makes Ventripoint Diagnostics the 45,987th largest company in the world by revenue and 1,053rd in Canada.
Revenue (ttm)
247.77K
Revenue Growth
+23.68%
P/S Ratio
117.47
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.36M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 179.93K | 84.76K | 89.06% |
| Dec 31, 2024 | 95.17K | 45.99K | 93.51% |
| Dec 31, 2023 | 49.18K | -18.98K | -27.85% |
| Dec 31, 2022 | 68.17K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 36.02K | -45.01K | -55.55% |
| Dec 31, 2019 | 81.02K | 20.85K | 34.64% |
| Dec 31, 2018 | 60.18K | 21.27K | 54.68% |
| Dec 31, 2017 | 38.91K | -170.57K | -81.43% |
| Dec 31, 2016 | 209.48K | 158.18K | 308.38% |
| Dec 31, 2015 | 51.30K | -77.16K | -60.07% |
| Dec 31, 2014 | 128.45K | 57.51K | 81.05% |
| Dec 31, 2013 | 70.95K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 24.92M |
| Perimeter Medical Imaging AI | 3.03M |
| Cheelcare | 2.32M |
| Conavi Medical | 845.00K |
| Theralase Technologies | 802.46K |
| Frequency Exchange | 647.43K |
| MedX Health | 569.79K |
| NuGen Medical Devices | 148.72K |
Ventripoint Diagnostics News
- 12 days ago - VentriPoint Diagnostics Ltd To Host Shareholder Call Transcript - GuruFocus
- 13 days ago - Ventripoint Diagnostics Transcript: Investor update - Transcripts
- 16 days ago - Ventripoint Provides Corporate Update and Announces Shareholder Videoconference Call - TheNewswire
- 4 weeks ago - Ventripoint Announces Successful Completion of Annual Quality and Regulatory Audits - TheNewswire
- 5 weeks ago - Ventripoint Issues Shares for Payment of Debenture Interest - TheNewswire
- 6 weeks ago - Ventripoint Closes First Tranche of Private Placement Financing and Engages Strategic Advisors to Accelerate Commercialization of VMS+™ Technology - TheNewswire
- 7 weeks ago - Ventripoint Diagnostics MD&A: Q2 2026 - Filings
- 7 weeks ago - Ventripoint Diagnostics Report: Q2 2026 - Filings